Clinical and Experimental Reproductive Medicine

  • 제35권1호
  • /
  • Pages.69-76
  • /
  • 2008
  • /
  • 2233-8233(pISSN)
  • /
  • 2233-8241(eISSN)
대한생식의학회 (The Korean Society for Reproductive Medicine)
권호 표지

한국 불임 여성에서 난포자극호르몬 수용체 유전자형과 체외수정 및 배아이식술 임상 결과와의 관련성

Relationship between FSH Receptor Genotype and Clinical Outcomes of IVF-ET in Infertile Korean Women

  • 문미혜 (관동대학교 의과대학 제일병원 생식생물학 및 불임연구실) ;
  • 최혜원 (관동대학교 의과대학 제일병원 생식생물학 및 불임연구실) ;
  • 김민지 (관동대학교 의과대학 제일병원 생식생물학 및 불임연구실) ;
  • 이형송 (관동대학교 의과대학 제일병원 생식생물학 및 불임연구실) ;
  • 차선화 (관동대학교 의과대학 제일병원 산부인과학교실) ;
  • 송인옥 (관동대학교 의과대학 제일병원 산부인과학교실) ;
  • 궁미경 (관동대학교 의과대학 제일병원 산부인과학교실) ;
  • 전진현 (관동대학교 의과대학 제일병원 생식생물학 및 불임연구실)
  • Moon, Mi-Hye (Laboratory of Reproductive Biology & Infertility, Cheil General Hospital & Women's Healthcare Center, Kwandong University College of Medicine) ;
  • Choi, Hye-Won (Laboratory of Reproductive Biology & Infertility, Cheil General Hospital & Women's Healthcare Center, Kwandong University College of Medicine) ;
  • Kim, Min-Jee (Laboratory of Reproductive Biology & Infertility, Cheil General Hospital & Women's Healthcare Center, Kwandong University College of Medicine) ;
  • Lee, Hyoung-Song (Laboratory of Reproductive Biology & Infertility, Cheil General Hospital & Women's Healthcare Center, Kwandong University College of Medicine) ;
  • Cha, Sun-Hwa (Department of Obstetrics and Gynecology, Cheil General Hospital & Women's Healthcare Center, Kwandong University College of Medicine) ;
  • Song, In-Ok (Department of Obstetrics and Gynecology, Cheil General Hospital & Women's Healthcare Center, Kwandong University College of Medicine) ;
  • Koong, Mi-Kyoung (Department of Obstetrics and Gynecology, Cheil General Hospital & Women's Healthcare Center, Kwandong University College of Medicine) ;
  • Jun, Jin-Hyun (Laboratory of Reproductive Biology & Infertility, Cheil General Hospital & Women's Healthcare Center, Kwandong University College of Medicine)
  • 발행 : 2008.03.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

목 적: 본 연구에서는 한국 불임 여성의 난포자극호르몬 수용체 유전자형의 분포 빈도를 파악하고, 체외수정 시술에서 난포자극호르몬 수용체 유전자형에 따른 과배란 유도 과정에서의 난소 반응과 각종 임상 결과와의 관련성을 알아보고자 하였다. 연구방법: 연구대상은 제일병원에 내원한 여성 불임 환자 1, 020명을 대상으로 난포자극호르몬 수용체의 유전자형, 즉 Thr307Ala (T/A)과 Asn680Ser (N/S)을 조사하였으며, 이들 중에서 과배란 유도와 체외수정 및 배아이식술을 시행한 302주기에서의 임상 결과를 이들의 유전자형에 따라 비교하였다. 결 과: 대상 환자에서 난포자극호르몬 수용체의 Thr307Ala와 Asn680Ser의 유전자형 빈도는 TT/NN 군이 44.80% (n=457), TA/NS 군이 41.96% (n=428) 그리고 AA/SS군이 10.49% (n=107)의 분포로 조사되었다. 과배란 유도에서의 각 유전자형에 따른 대상 환자의 나이, 난소 반응에 관련된 사용한 난포자극호르몬의 용량과 이에 따른 혈중 에스트라디올의 농도와 채취된 난자의 수 등에서 통계적으로 유의한 차이가 나타나지 않았다. 그러나 배아이식 후 AA/SS 유전자형 환자에서의 착상률이 TT/NN에 비해 통계적으로 유의하게 높게 나타났다 (24.5% vs 15.7%, p<0.05) 결 론: 대표적인 세 가지 TT/NN, TA/NS 그리고 AA/SS 유전자형에 따른 과배란 유도에서의 난소 반응은 통계적으로 의미있는 차이를 나타내지 않았다. 그러나 각각의 유전자형에 따라 난소 반응과 임상 결과가 다소 차이가 나타남을 확인할 수 있었으며, 이에 대한 추가적인 연구가 필요할 것으로 생각된다.

Objective: The purposes of this study were to determine the distribution of follicle-stimulating hormone receptor (FSHR) genotypes in infertile Korean women and to evaluate the relationship between FSHR genotypes and clinical outcomes of IVF-ET cycles. Methods: Genomic DNA was extracted from peripheral blood in 1, 020 of infertile Korean women. Genotypes of FSHR at Thr307Ala (T/A) and Asn680Ser (N/S) were screened by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Clinical outcomes related to the genotypes of FSHR were evaluated in IVF-ET cycles (n=302) with controlled ovarian hyperstimulation (COH) of infertile women under 40 years old. Results: In a population of 1, 020 infertile Korean women, the frequency of TT/NN, TA/NS and AA/SS for the major variant Thr307Ala and Asn680Ser was 44.80%, 41.96% and 10.49%, respectively. There was no significant difference in characteristics of ovarian response and clinical pregnancy rate among the major genotypes of FSHR in IVF-ET cycles with COH. However, implantation rate of AA/SS patients was significantly higher than that of TT/NN patients (24.5% vs 15.7%, p<0.05). Conclusion: This study showed that FSHR genotype was not directly associated with ovarian response in IVF-ET cycles with COH. The relationship between clinical outcomes and FSHR genotypes of patients should be substantiated by further studies.

키워드

참고문헌

  1. Wheeler C, Ben-Rafael Z, Benjamini Y, Blasco L, Flickinger G, Tureck RW, et al. Repetitive ovarian response to gonadotropin stimulation in an in vitro fertilization program. Gynecol Obstet Invest 1989; 28: 152-5 https://doi.org/10.1159/000293554
  2. Fauser BC, Van Heusden AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev 1997; 18: 71-106 https://doi.org/10.1210/er.18.1.71
  3. Devroey P, Bourgain C, Macklon NS, Fauser BC. Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol Metab 2004; 15: 84-90
  4. Macklon NS, Stouffer RL, Guidice LC, Fauser BC. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev 2006; 27: 170-207 https://doi.org/10.1210/er.2005-0015
  5. Seifer DB, Lambert-Messerlian G, Hogan JW, Gardiner AC, Blazar AS, Berk CA. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil Steril 1997; 67: 110-4 https://doi.org/10.1016/S0015-0282(97)81865-1
  6. Gurgan T, Urman B, Yarali H, Duran HE. Follicle-stimulating hormone levels on cycle day 3 to predict ovarian response in women undergoing controlled ovarian hyperstimulation for in vitro fertilization using a flare-up protocol. Fertil Steril 1997; 68: 483-7 https://doi.org/10.1016/S0015-0282(97)00246-X
  7. Creus M, Penarrubia J, Fabregues F, Vidal E, Carmona F, Casamitjana R, et al. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 2000; 15: 2341-6 https://doi.org/10.1093/humrep/15.11.2341
  8. Kligman I, Rosenwaks Z. Differentiating clinical profiles: prediction good responders, poor responders, and hyperresponders. Fertil Steril 2001; 76: 1185-9 https://doi.org/10.1016/S0015-0282(01)02893-X
  9. Nahum R, Shifren JL, Chang Y, Leykin L, Isaacson K, Toth TL. Antral follicle assessment as a tool for predicting outcome in IVF-is it a better predictor than age and FSH? J Assist Reprod Genet 2001; 18: 151-5 https://doi.org/10.1023/A:1009424407082
  10. Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients? Br J Obstet Gynaecol 2004; 111: 1248-53 https://doi.org/10.1111/j.1471-0528.2004.00452.x
  11. Hendriks DJ, Mol BW, Bancsi LF, Te Velde ER, Broekmans FJ. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a metaanalysis and comparison with basal follicle-stimulating hormone level. Fertil Steril 2005; 83: 291-301 https://doi.org/10.1016/j.fertnstert.2004.10.011
  12. Verberg MF, Eijkemans MJ, Macklon NS, Heijnen EM, Fauser BC, Broekmans FJ. Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF. Hum Reprod 2007; 22: 1919-24 https://doi.org/10.1093/humrep/dem089
  13. Liu JY, Gromoll J, Cedars MI. Identification of allelic variants in the follicle-stimulating hormone receptor genes of females with or without hypergonadotropic amenorrhea. Fertil Steril 1998; 70: 326-31 https://doi.org/10.1016/S0015-0282(98)00151-4
  14. Simoni M, Gromoll J, Hoppner W, Kamischke A, Krafft T, Stahle D, et al. Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab 1999; 84: 751-5 https://doi.org/10.1210/jc.84.2.751
  15. Mayorga MP, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. Ovarian response to follicle-stimulating hormone stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 2000; 85: 3365-9 https://doi.org/10.1210/jc.85.9.3365
  16. Simoni M, Nieschlag E, Gromoll J. Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Hum Reprod Update 2002; 8: 413 -21 https://doi.org/10.1093/humupd/8.5.413
  17. De Castro F, Ruiz R, Montoro L, Perez-Hernandez D, Sanchez- Casas Padilla E, Real LM, et al. Role of follicle stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. Fertil Steril 2003; 80: 571-6 https://doi.org/10.1016/S0015-0282(03)00795-7
  18. Behre HM, Greb RR, Mempel A, Sonntag B, Kiesel L, Kaltwasser P, et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics 2005; 15: 451-6 https://doi.org/10.1097/01.fpc.0000167330.92786.5e
  19. 홍승범, 박동욱, 신미라, 최수진, 이선희, 송인옥 등. 정 산 정자 소견을 나타내는 불임 부부에서 일반적인 체 외수정과 세포질내 정자주입술을 병행하는 분할 수정 법의 효용성. 대한생식의학회지 2007; 34: 305-12
  20. Daelemans C, Smits G, de Maertelaer V, Costagliola S, Englert Y, Vassart G, et al. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by folliclestimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab 2004; 89: 6310-5 https://doi.org/10.1210/jc.2004-1044
  21. Sudo S, Kudo M, Wada S, Sato O, Hsueh AJ, Fujimoto S. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod 2002; 8: 893-9 https://doi.org/10.1093/molehr/8.10.893
  22. Klinkert E, te Velde E, Weima S, van Zandvoort P, Hansen R, Nilsson P, et al. FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF. Reprod Biomed Online 2006; 13: 687-95 https://doi.org/10.1016/S1472-6483(10)60660-8
  23. Laven JS, Mulders AG, Suryandari DA, Gromoll J, Nieschlag E, Fauser BC, et al. Follicle stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility. Fertil Steril 2003; 80: 986-92 https://doi.org/10.1016/S0015-0282(03)01115-4
  24. Greb RR, Grieshaber K, Gromoll J, Sonntag B, Nieschlag E, Kiesel L, Simoni M. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab 2005; 90: 4866-72 https://doi.org/10.1210/jc.2004-2268
  25. Davis D, Liu X, Segaloff DL. Identification of the sites of N-linked glycosylation on the follicle-stimulating hormone (FSH) receptor and assessment of their role in FSH receptor function. Mol Endocrinol 1995; 9: 159-70 https://doi.org/10.1210/me.9.2.159
  26. Ulloa-Aguirre A, Timossi C. Structure-function relationship of follicle-stimulating hormone and its receptor. Hum Reprod Update 1998; 4: 260-83 https://doi.org/10.1093/humupd/4.3.260
  27. Barrios-De-Tomasi J, Timossi C, Merchant H, Quintanar A, Avalos JM, Andersen CY, et al. Assessment of the in vitro and in vivo biological activities of the human follicle-stimulating isohormones. Mol Cell Endocrinol 2002; 186: 189-98 https://doi.org/10.1016/S0303-7207(01)00657-8
  28. 윤지성, 최영민, 임경실, 허창영, 가영제, 정재훈 등. 체 외수정 시술시 난포자극호르몬 수용체 유전자 다형성 이 과배란 유도 및 임신 결과에 미치는 영향. 대한불임학회지 2004; 31: 133-9
  29. Jun JK, Yoon JS, Ku S-Y, Choi YM, Hwang KR, Park SY, et al. Follicle-stimulating hormone receptor gene polymorphism and ovarian response to controlled ovarian hyperstimulation for IVF-ET. J Hum Genet 2006; 51: 665-70 https://doi.org/10.1007/s10038-006-0005-5